Search Articles
TYLER, Texas – Three generic drugmakers must stop producing an alternative to Pozen’s migraine therapy Treximet until the patent runs out, a federal judge ruled.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.